BROOKS

Brooks Laboratories Share Price Brooks Laboratories

₹93.6
-1.95 (-2.04%)
30 March, 2024 11:09 BSE: 533543 NSE: BROOKSISIN: INE650L01011

Start SIP in Brooks Laboratories

Start SIP

Brooks Laboratories Performance

Day Range

  • Low 92
  • High 99
₹ 93

52 Week Range

  • Low 57
  • High 186
₹ 93
  • Open Price96
  • Previous Close96
  • Volume53639

Brooks Laboratories Share Price

  • Over 1 Month -21.01%
  • Over 3 Month -37.37%
  • Over 6 Month 3.83%
  • Over 1 Year 41.78%

Brooks Laboratories Key Statistics

P/E Ratio -17.2
PEG Ratio -0.4
Market Cap Cr 246
Price to Book Ratio 3.3
EPS -3.1
Dividend 0
Relative Strength Index 31.85
Money Flow Index 53.04
MACD Signal -8.36
Average True Range 7.43
Brooks Laboratories Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 22241613
Operating Expenses Qtr Cr 21231613
Operating Profit Qtr Cr 1200
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 11-1-1
IndicatorMar 2023
Total Revenue Annual Cr 56
Operating Expenses Annual Cr 61
Operating Profit Annual in Cr -6
Depreciation Cr 2
Interest Annual Cr 1
Tax Annual Cr 0
Net Profit Annual Cr -8
IndicatorMar 2023
Cash from Operating Activity Annual Cr 1
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 57
Fixed Assets Annual Cr 15
Total Non Current Assets Annual Cr 65
Total Current Assets Annual Cr 28
Total Assets Annual Cr 92
IndicatorMar 2023
Book Value Per Share Annual Rs 23
ROE Annual % -14
ROCE Annual % -12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % -10
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 22241613
Operating Expenses Qtr Cr 21231613
Operating Profit Qtr Cr 1200
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr -4-2-4-4
IndicatorMar 2023
Total Revenue Annual Cr 63
Operating Expenses Annual Cr 90
Operating Profit Annual in Cr -26
Depreciation Cr 7
Interest Annual Cr 2
Tax Annual Cr -7
Net Profit Annual Cr -21
IndicatorMar 2023
Cash from Operating Activity Annual Cr -14
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 11
Net Cash Flow Annual Cr -3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 74
Fixed Assets Annual Cr 15
Total Non Current Assets Annual Cr 82
Total Current Assets Annual Cr 28
Total Assets Annual Cr 110
IndicatorMar 2023
Book Value Per Share Annual Rs 30
ROE Annual % -28
ROCE Annual % -43
Total Debt to Total Equity Annual -
EBDIT Annual Margin % -41

Brooks Laboratories Technicals

EMA & SMA

Current Price
₹93.6
-1.95 (-2.04%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹105.82
  • 50 Day
  • ₹118.31
  • 100 Day
  • ₹121.34
  • 200 Day
  • ₹114.95
  • 20 Day
  • ₹106.53
  • 50 Day
  • ₹124.63
  • 100 Day
  • ₹130.50
  • 200 Day
  • ₹111.77

Brooks Laboratories Resistance and Support

PIVOT
₹94.8
Resistance
First Resistance 97.60
Second Resistance 101.60
Third Resistance 104.40
RSI 31.85
MFI 53.04
MACD Single Line -8.36
MACD -8.47
Support
First Resistance 90.80
Second Resistance 88.00
Third Resistance 84.00

Brooks Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 76,904 7,690,400 100
Week 65,141 6,514,075 100
1 Month 83,739 5,072,060 60.57
6 Month 99,627 6,748,710 67.74

Brooks Laboratories Result Highlights

Brooks Laboratories Synopsis

NSE-Medical-Generic Drugs

Brooks Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 55.54 Cr. and Equity Capital is Rs. 24.70 Cr. for the Year ended 31/03/2023. Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267.
Market Cap 246
Sales 74
Shares in Float 0.94
No of funds 2
Yield
Book Value 4.11
U/D Vol ratio 0.6
LTDebt / Equity
Alpha 0.06
Beta 1.18

Brooks Laboratories

Owner NameDec-23Sep-23Aug-23Jun-23
Promoters 63.59%63.59%63.59%66.41%
Mutual Funds 3.86%2.46%1.25%
Foreign Portfolio Investors
Individual Investors 25.22%26.88%27.8%27.84%
Others 7.33%7.07%7.36%5.75%

Brooks Laboratories Management

Name Designation
Ms. Sonia Gupta Independent Director
Mr. Deepak Mahajan Independent Director
Mr. Rajnish Kumar Bedi Independent Director
Mr. Jitendra Pratap Singh Whole Time Director
Mr. Durga Shankar Maity Additional Director
Mr. Bhushan Singh Rana Additional Director

Brooks Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Brooks Laboratories Corporate Action

Date Purpose Remarks
2024-01-31 Quarterly Results
2024-01-24 Rights & Preferential issue
2023-11-09 Quarterly Results
2023-08-10 Quarterly Results
2023-07-18 Rights issue of Equity Shares

Brooks Laboratories MF Shareholding

Brooks Laboratories FAQs

What is Share Price of Brooks Laboratories ?

Brooks Laboratories share price is ₹93 As on 30 March, 2024 | 10:55

What is the Market Cap of Brooks Laboratories ?

The Market Cap of Brooks Laboratories is ₹245.7 Cr As on 30 March, 2024 | 10:55

What is the P/E ratio of Brooks Laboratories ?

The P/E ratio of Brooks Laboratories is -17.2 As on 30 March, 2024 | 10:55

What is the PB ratio of Brooks Laboratories ?

The PB ratio of Brooks Laboratories is 3.3 As on 30 March, 2024 | 10:55

Q2FY23